SAN CARLOS, CA — Ferrokin Biosciences Inc reported today in a filing with the U.S. Securities and Exchange Commission it had raised $3M of a $6M private offering. Companies file this special form with the U.S. Securities and Exchange Commission in the majority of cases when closing new funding.

Ferrokin Biosciences Inc did not disclose revenue figures according to the SEC Filing detailing the transaction. The type of investment being offered was listed as debt (opposed to equity, warrants, or other types of investment options). Ferrokin Biosciences Inc noted they began raising the money on February 10, 2012. As of today, $6M of the $6M offering has been sold to private investors.

Digging into Ferrokin Biosciences Inc's fundraising history, Ferrokin Biosciences Inc has filed 2 fundraising documents with the U.S. Securities and Exchange Commission. Their last filing with the SEC on June 3, 2010 noted $12M in new investment. Previous to this filing, Ferrokin Biosciences Inc had a $25.4M fund raise on October 9, 2008.

The SEC Filing can be viewed in its entirety by clicking here: Ferrokin Biosciences Inc Form D SEC Filing.